To achieve targeted and tumor-specific treatment, in addition to targeting GPC3 on HCC cell membranes, the use of Fe3O4 as a contrast agent for PAI not only enhances the accuracy of small HCC detection but also produces a Fenton-like reaction in the tumor microenvironment (TME). The gene discussed is GPC3; the disease is hepatocellular carcinoma.